Chitayat–Haj–Chahine syndrome
Chitayat–Haj–Chahine syndrome is a rare genetic disorder characterized by a range of clinical features including distinctive facial features, cardiomyopathy, and developmental delay. This syndrome was first described in the medical literature by Chitayat, Haj, and Chahine, who identified the condition in a small number of patients, delineating its unique clinical presentation and genetic basis.
Clinical Features[edit | edit source]
Chitayat–Haj–Chahine syndrome is marked by a constellation of clinical signs and symptoms that vary among affected individuals. Key features of the syndrome include:
- Distinctive Facial Features: Patients may exhibit a unique facial morphology, including a prominent forehead, deep-set eyes, and a small chin.
- Cardiomyopathy: A significant proportion of individuals with this syndrome develop cardiomyopathy, a condition characterized by the weakening of the heart muscle that can lead to heart failure.
- Developmental Delay: Affected individuals may experience delays in reaching developmental milestones. The extent of developmental delay can vary widely among patients.
- Skeletal Anomalies: Some patients may present with skeletal abnormalities, including scoliosis or other spinal deformations.
Genetics[edit | edit source]
Chitayat–Haj–Chahine syndrome is believed to be caused by mutations in a specific gene, although the exact genetic mechanism and the gene involved have yet to be fully elucidated. The condition is thought to follow an autosomal recessive pattern of inheritance, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Chitayat–Haj–Chahine syndrome is based on a combination of clinical evaluation, detailed patient history, and genetic testing. Given the rarity of the syndrome, diagnosis can be challenging, and it often requires the expertise of a multidisciplinary team of specialists.
Management and Treatment[edit | edit source]
There is no cure for Chitayat–Haj–Chahine syndrome, and treatment is symptomatic and supportive. Management strategies may include:
- Cardiac Care: Regular monitoring and treatment for cardiomyopathy and other heart-related issues.
- Developmental Support: Early intervention programs and therapies to address developmental delays and support cognitive and physical development.
- Orthopedic Interventions: Treatment for skeletal anomalies, which may include surgery or physical therapy.
Prognosis[edit | edit source]
The prognosis for individuals with Chitayat–Haj–Chahine syndrome varies depending on the severity of symptoms and the presence of cardiomyopathy. Early diagnosis and comprehensive management can improve the quality of life for affected individuals.
See Also[edit | edit source]
Chitayat–Haj–Chahine syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD